{"slug":"ecog-acrin","tag":"ecog-acrin","variants":["ecog-acrin"],"description":"No description yet","count":3,"kinds":{"person":3},"related":[{"slug":"breast","tag":"breast","shared":1},{"slug":"de-escalation","tag":"de-escalation","shared":1},{"slug":"head-and-neck","tag":"head-and-neck","shared":1},{"slug":"immunotherapy","tag":"immunotherapy","shared":1},{"slug":"prostate","tag":"prostate","shared":1},{"slug":"trialist","tag":"trialist","shared":1}],"records":[{"id":"joseph-sparano","kind":"person","name":"Joseph A. Sparano","route":"/people/joseph-sparano/","tldr":"Led TAILORx, which showed most women with intermediate Oncotype scores can safely skip chemotherapy."},{"id":"christopher-sweeney","kind":"person","name":"Christopher J. Sweeney","route":"/people/christopher-sweeney/","tldr":"Led CHAARTED, which showed adding docetaxel to hormone therapy extends survival in newly metastatic prostate cancer."},{"id":"barbara-burtness","kind":"person","name":"Barbara Burtness","route":"/people/barbara-burtness/","tldr":"Led KEYNOTE-048, which made pembrolizumab first-line therapy for recurrent or metastatic head and neck cancer."}]}